Overview

Alitretinoin in the Treatment of Chronic Hand Eczema

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the safety and efficacy of alitretinoin in chronic hand eczema that is refractory to topical corticosteroids.
Phase:
Phase 3
Details
Lead Sponsor:
Basilea Pharmaceutica
Treatments:
Alitretinoin
Tretinoin